| Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... Cancer discovery 4 (11), 1342-1353, 2014 | 525 | 2014 |
| Exploring genomic alteration in pediatric cancer using ProteinPaint X Zhou, MN Edmonson, MR Wilkinson, A Patel, G Wu, Y Liu, Y Li, Z Zhang, ... Nature genetics 48 (1), 4-6, 2016 | 325 | 2016 |
| Quantitative functions of Argonaute proteins in mammalian development D Wang, Z Zhang, E O'Loughlin, T Lee, S Houel, D O'Carroll, ... Genes & development 26 (7), 693-704, 2012 | 226 | 2012 |
| Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome M Rusch, J Nakitandwe, S Shurtleff, S Newman, Z Zhang, MN Edmonson, ... Nature communications 9 (1), 3962, 2018 | 180 | 2018 |
| MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI (3) K pathway D Wang, Z Zhang, E O’Loughlin, L Wang, X Fan, EC Lai, R Yi Nature cell biology 15 (10), 1153-1163, 2013 | 153 | 2013 |
| Genomes for Kids: The scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing S Newman, J Nakitandwe, CA Kesserwan, EM Azzato, DA Wheeler, ... Cancer Discovery 11 (12), 3008-3027, 2021 | 140 | 2021 |
| High-efficiency RNA cloning enables accurate quantification of miRNA expression by deep sequencing Z Zhang, JE Lee, K Riemondy, EM Anderson, R Yi Genome biology 14, 1-13, 2013 | 97 | 2013 |
| Stem cell quiescence acts as a tumour suppressor in squamous tumours AC White, JK Khuu, CY Dang, J Hu, KV Tran, A Liu, S Gomez, Z Zhang, ... Nature cell biology 16 (1), 99-107, 2014 | 88 | 2014 |
| Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation SJ Jackson, Z Zhang, D Feng, M Flagg, E O’Loughlin, D Wang, N Stokes, ... Development 140 (9), 1882-1891, 2013 | 83 | 2013 |
| Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov. 2014; 4: 1342–1353. doi: 10.1158/2159-8290 F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... CD-14-0622.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 58 | |
| Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 … EP Hamilton, JS Wang, TJ Pluard, SRD Johnston, A Morikawa, EC Dees, ... Journal of Clinical Oncology 39 (15_suppl), 1018-1018, 2021 | 31 | 2021 |
| St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project and the International Cancer Genome Consortium. Genomic landscape of Ewing sarcoma … F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... Cancer Discov 4, 1342-1353, 2014 | 29 | 2014 |
| Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer C Furman, X Puyang, Z Zhang, ZJ Wu, D Banka, KB Aithal, LA Albacker, ... Molecular cancer therapeutics 21 (6), 890-902, 2022 | 17 | 2022 |
| Phase 1b study of H3B-6545 in combination with palbociclib in women with metastatic estrogen receptor–positive (ER+), human epidermal growth factor receptor 2 (HER2)-negative … SRD Johnston, TJ Pluard, JS Wang, EP Hamilton, D Juric, CR Scholz, ... Journal of Clinical Oncology 39 (15_suppl), e13025-e13025, 2021 | 10 | 2021 |
| Abstract PD8-06: Phase I/II trial of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth … EP Hamilton, JS Wang, T Pluard, S Johnston, AA Morikawa, CE Dees, ... Cancer Research 81 (4_Supplement), PD8-06-PD8-06, 2021 | 9 | 2021 |
| Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. Nat Commun. 2018 M Rusch, J Nakitandwe, S Shurtleff, S Newman, Z Zhang, M Edmonson | 7 | |
| Genomic landscape of Ewing Sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov. doi: 10.1158/2159-8290 F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... CD-14-0622, 2014 | 6 | 2014 |
| Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov. 2014; 4: 1342-53 F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... CD-14-0622, 0 | 6 | |
| Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWT and ERaMUT breast cancer M Korpal, C Furman, X Puyang, Z Zhang, Z Wu, D Banka, S Das, ... Cancer Research 81 (4_Supplement), PS12-23-PS12-23, 2021 | 2 | 2021 |
| Defining the microenvironment landscape of bladder cancer using highly multiplexed spatial genomic and proteomic analysis JW Reeves, Z Zhang, ZK Norgaard, DM Zhou, JJ Gong, Y Liang, S Das, ... BioRxiv, 675926, 2019 | 2 | 2019 |
